The international PROGRESS registry of patients with severe sepsis: Drotrecogin alfa (activated) use and patient outcomes

Critical Care

Volumn 13, Issue 3, 2009, Pages

  Martin, Greg ^a   Brunkhorst, Frank M ^b   Janes, Jonathan M ^c   Reinhart, Konrad ^b   Sundin, David P ^c   Garnett, Kassandra ^d   Beale, Richard ^e  

^a EMORY UNIVERSITY   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c ELI LILLY AND COMPANY   (United States)

^d i3 StatProbe ^*  (United States)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; ANTIINFECTIVE AGENT; PROTEIN C; RECOMBINANT PROTEIN;

ADULT; APACHE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GERMANY; HEALTH CARE QUALITY; HUMAN; INTENSIVE CARE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REGISTER; RESPIRATORY TRACT DISEASE; RISK REDUCTION; SEPSIS; TREATMENT OUTCOME; UNITED STATES; HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; SURVIVAL RATE;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEIN C; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 67949120336     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7936     Document Type: Article

References (31)

1. Marshall JC Such stuff as dreams are made on: Mediator-directed therapy in sepsis Nat Rev Drug Discov 2003, 2:391-405. 10.1038/nrd1084 12750742
2. Martin GS Mannino DM Eaton S Moss M The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139 12700374
3. Natanson C Esposito CJ Banks SM The sirens' songs of confirmatory sepsis trials: Selection bias and sampling error Crit Care Med 1998, 26:1927-1931. 10.1097/00003246-199812000-00001 9875887
4. Riedemann NC Guo RF Ward PA The enigma of sepsis J Clin Invest 2003, 112:460-467. 171398 12925683
5. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Fisher CJ Jr Recombinant human protein, CWEi Efficacy and safety of recombinant human activated protein C for severe sepsis New Engl J Med 2001, 344:699-709. 10.1056/ NEJM200103083441001 11236773
6. Bernard GR Ely EW Wright TJ Fraiz J Stasek JE Jr Russell JA Mayers I Rosenfeld BA Morris PE Yan SB Helterbrand JD Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis Crit Care Med 2001, 29:2051-2059. 10.1097/ 00003246-200111000-00003 11700394
7. Bertolini G Rossi C Anghileri A Livigni S Addis A Poole D Use of Drotrecogin alfa (activated) in Italian intensive care units: The results of a nationwide survey Intensive Care Med 2007, 33:426-434. 10.1007/s00134-007-0554-x 17325836
8. Dhainaut JF Payet S Vallet B Franca LR Annane D Bollaert PE Le TY Runge I Malledant Y Guidet B Le LK Launois R PREMISS Study Group Cost-effectiveness of activated protein C in real-life clinical practice Crit Care 2007, 11:R99. 2556742 17822547 10.1186/cc6116
9. Kanji S Perreault MM Chant C Williamson D Burry L Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: A Canadian multicenter observational study Intensive Care Med 2007, 33:517-523. 10.1007/s00134-007-0555-9 17325837
10. Kubler A Mayzner-Zawadzka E Durek G Gaszyski W Karpel E Mikaszewska-Sokolewicz M Majak P Results of severe sepsis treatment program using recombinant human activated protein C in Poland Medical Science Monitor 2006, 12:CR107-112. 16501420
11. Ridley S Lwin A Wyncoll D Lippett S Watson D Gunning K Higgins D Drotrecogin alfa (activated): Diffusion from clinical trials to clinical practice Eur J Anaesthesiol 2008, 25:211-216. 10.1017/S0265021507002992 18031590
12. Rowan KM Welch CA North E Harrison DA Drotrecogin alfa (activated): real-life use and outcomes for the UK Crit Care 2008, 12:R58. 2447613 18430215 10.1186/cc6879
13. Spriet I Meersseman W Wilmer A Meyfroidt G Casteels M Willems L Evaluation of drotrecogin alpha use in a Belgian university hospital Pharm World Sci 2006, 28:290-295. 17111246 10.1007/s11096-006-9045-3
14. Vincent JL Laterre PF Decruyenaere J Spapen H Raemaekers J Damas F Rogiers P Sartral M Haentjens T Nelson D Janes J A registry of patients treated with drotrecogin alfa (activated) in Belgian intensive care units - an observational study Acta Clinica Belgica 2008, 63:25-30. 18386762
15. Wheeler A Steingrub J Schmidt GA Sanchez P Jacobi J Linde-Zwirble W Bates B Qualy RL Woodward B Zeckel M A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial Crit Care Med 2008, 36:14-23. 10.1097/ 01.CCM.0000298309.73776.CB 18158435
16. Eichacker PQ Natanson C Increasing evidence that the risks of rhAPC may outweigh its benefits Intensive Care Med 2007, 33:396-399. 10.1007/ s00134-007-0556-8 17325833
17. Williams MD Macias W Rustige J Safety of drotrecogin alfa (activated): A fair comparison requires consistent definitions Intensive Care Med 2007, 33:1487-1488. 10.1007/s00134-007-0709-9 17563878
18. Beale R Reinhart K Brunkhorst F Dobb G Levy M Martin G Martin C Ramsay G Silva E Vallet B Vincent JL Janes JM Sarwat S Williams MD Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an International Sepsis Registry Infection 2009, 37:222-232. 19404580
19. Bone RC Balk RA Cerra FB Dellinger RP Fein AM Knaus WA Schein RM Sibbald WJ Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644 1303622
20. Levy MM Fink MP Marshall JC Abraham E Angus D Cook D Cohen J Opal SM Vincent JL Ramsay G SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B 12682500
21. D'Agostino RBJ D'Agostino RBS Estimating treatment effects using observational data JAMA 2007, 297:314-316. 10.1001/jama.297.3.314 17227985
22. Zhang JM Yu KFP What's the relative risk?: A method of correcting the odds ratio in cohort studies of common outcomes JAMA 1998, 280:1690-1691. 10.1001/jama.280.19.1690 9832001
23. Dellinger RP Carlet JM Masur H Gerlach H Calandra T Cohen J Gea-Banacloche J Keh D Marshall JC Parker MM Ramsay G Zimmerman JL Vincent JL Levy MM Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2398-y 14997291
24. Dellinger RP Levy MM Carlet JM Bion J Parker MM Jaeschke R Reinhart K Angus DC Brun-Buisson C Beale R Calandra T Dhainaut JF Gerlach H Harvey M Marini JJ Marshall J Ranieri M Ramsay G Sevransky J Thompson BT Townsend S Vender JS Zimmerman JL Vincent JL Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 2008, 34:17-60. 2249616 18058085 10.1007/ s00134-007-0934-2
25. Afessa B Gajic O Keegan MT Seferian EG Hubmayr RD Peters SG Impact of introducing multiple evidence-based clinical practice protocols in a medical intensive care unit: A retrospective cohort study BMC Emerg Med 2007, 7:10. 1965465 17686165 10.1186/1471-227X-7-10
26. Castro R Regueira T Aguirre ML Llanos OP Bruhn A Bugedo G Dougnac A Castillo L Andresen M Hernandez G An evidence-based resuscitation algorithm applied from the emergency room to the ICU improves survival of severe septic shock Minerva Anestesiol 2008, 74:223-231. 18356807
27. El Solh AA Akinnusi ME Alsawalha LN Pineda LA Outcome of septic shock in older adults after implementation of the sepsis "bundle" J Am Geriatr Soc 2008, 56:272-278. 10.1111/j.1532-5415.2007.01529.x 18047494
28. Ferrer R Artigas A Levy MM Blanco J Gonzalez-Diaz G Garnacho-Montero J Ibanez J Palencia E Quintana M de la Torre-Prados MV Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain JAMA 2008, 299:2294-2303. 10.1001/ jama.299.19.2294 18492971
29. Nguyen HB Oh J Otero RM Burroughs K Wittlake WA Corbett SW Standardization of severe sepsis management: A survey of methodologies in academic and community settings J Emerg Med 2008.
30. Talmor D Greenberg D Howell MD Lisbon A Novack V Shapiro N The costs and cost-effectiveness of an integrated sepsis treatment protocol Crit Care Med 2008, 36:1168-1174. 10.1097/CCM.0b013e318168f649 18379243
31. Karlsson S Varpula M Ruokonen E Pettila V Parviainen I la-Kokko TI Kolho E Rintala EM Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: The Finnsepsis study Intensive Care Med 2007, 33:435-443. 10.1007/s00134-006-0504-z 17225161